Hologic Inc. (HOLX), a Medical diagnostic equipment maker on Monday reported a wider net loss in the second-quarter of $51.1 million or $0.19 per share, from $40.2 million or $0.15 per share in the same period last year. The latest quarter results were weighed down by a spike in total costs and expenses from the prior-year quarter.
On an adjusted basis the company posted a profit of $93.8 million or $0.35 per share. On average, 20 analysts polled by Thomson Reuters expected earnings of $0.34 per share for the quarter. Analysts' estimates typically exclude special items.
Costs of expenses during the quarter rose to $607.1 million from $467.0 million in the same year-ago period.
Meanwhile, quarterly revenues climbed to $612.66 million from $471.16 million in the comparable quarter a year ago, while fourteen analysts expected to see revenues of $639.44 million for the quarter.
Looking forward to the third quarter, the company expects adjusted earnings in a range of between $0.36 per share and $0.37 per share and to record revenues between $625 million and $630 million. Analysts currently estimate earnings of $0.41 per share on revenues of $655.24 million.
Further, the company cut its fiscal year 2013 revenue guidance to a range between $2.53 billion and $2.55 billion from its prior estimate of $2.61 billion to $2.64 billion, the company also scaled down its full year earnings guidance to a range between $1.54 per share and $1.56 per share, from its previous guidance between $1.58 and $1.60 per share.
Analysts currently estimate earnings of $1.58 per share on revenues of $2.62 billion for fiscal year 2013.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.